|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Chemocentryx, Inc. (CCXI) |
|
|
$51.99 0.00 (0.00%) as of 4:30 Wed 10/19
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
28 |
|
|
|
Total
Direct Shares :
|
6,529,973 |
|
|
Total
Indirect Shares :
|
19,913,321 |
| |
%
Held by Insiders:
|
9.44% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Edwards Thomas A. |
Director |
2022-10-20 |
0 |
|
0 |
| Feczko Joseph M |
Director |
2022-10-20 |
0 |
2013-09-13 |
0 |
| Schall Thomas J. |
President and CEO, Director |
2022-10-20 |
0 |
|
0 |
| Jain Rita |
EVP, Chief Medical Officer, Director |
2022-10-20 |
0 |
2019-05-23 |
0 |
| Parker Geoffrey M. |
Director |
2022-10-20 |
0 |
2022-10-20 |
0 |
| Herron Jennifer Lyn |
Director |
2022-10-20 |
0 |
2022-06-28 |
0 |
| Tyree James L |
Director |
2022-10-20 |
0 |
2015-05-22 |
0 |
| Butt Tausif |
EVP, Chief Operating Officer |
2022-10-20 |
0 |
2021-05-07 |
0 |
| Cappel Markus J. |
Chief Bus. Officer & Treasurer |
2022-10-20 |
0 |
|
0 |
| Kanaya Susan M |
See Remarks, Director |
2022-10-20 |
0 |
2022-10-20 |
0 |
| Mckinnell Henry A |
Director |
2022-05-20 |
72,749 |
2016-11-03 |
0 |
| Kwan Pui San |
Principal Acctg Officer |
2021-03-01 |
3,232 |
|
0 |
| Vifor Fresenius Medical Care Renal Pharma Ltd. |
10% Owner |
2020-07-02 |
0 |
2021-10-12 |
5,194,085 |
| Singh Rajinder |
SVP, Research |
2019-04-15 |
10,614 |
2018-01-01 |
0 |
| Lucas Roger C |
Director |
2019-03-05 |
102,267 |
|
0 |
| Bekker Petrus |
Chief Medical Officer |
2017-07-13 |
59,839 |
|
0 |
| Klein Ira |
Director |
2015-05-22 |
16,216 |
2015-05-22 |
0 |
| Duliege Anne-Marie |
EVP, Chief of Strategic Dev. |
2014-11-18 |
0 |
2014-11-18 |
0 |
| Bvf Investments Llc |
See Explanation of Responses |
2013-09-11 |
0 |
2015-11-05 |
3,414,295 |
| Jaen Juan C. |
SVP, Drug Discovery & CSO |
2013-03-08 |
30,000 |
|
0 |
| Biotechnology Value Fund Ii Lp |
See Explanation of Responses |
2012-11-06 |
0 |
2012-11-06 |
4,778,067 |
| Techne Corp /mn/ |
10% Owner |
2012-02-13 |
6,235,056 |
2012-02-13 |
0 |
| Isaly Samuel D |
10% Owner |
2012-02-13 |
0 |
2012-02-13 |
908,509 |
| Penhoet Edward |
Director |
2012-02-13 |
0 |
2012-02-13 |
1,868,088 |
| Charo Israel |
|
|
0 |
|
0 |
| Lampert Mark N |
10% Owner |
|
0 |
2012-11-06 |
3,750,277 |
| Glaxosmithkline Plc |
Former 10% holder |
|
0 |
2018-10-16 |
0 |
| Fairey William |
|
|
0 |
|
0 |
|
|
